GlaxoSmithKline to Invest $245 Milion Upgrading Upper Providence Facility

GlaxoSmithKline, with a research lab in Collegeville, is the latest in a line of pharmaceutical manufacturers that are working on a potential coronavirus vaccine.

GlaxoSmithKline announced on Monday that it is planning to invest $245 million in upgrading its drug research and discovery hub in Upper Providence Township, writes Linda Loyd for

[uam_ad id=”51709″]


The company currently employs around 5,000 people in the region. It is now planning to create several new smart labs by building four floors in its new research facilities at its Collegeville site in Upper Providence Township.

The aim is for GSK to have close to 40 percent of its global pharmaceutical and drug development teams in place in Collegeville by 2018.

Read more about GlaxoSmithKline’s plans at here and check out previous MONTCO Today coverage of the company here.

[uam_ad id=”52088″]

Stay Connected, Stay Informed

Subscribe for great stories in your community!

"*" indicates required fields

This field is for validation purposes and should be left unchanged.